Global Leadership Initiative on Malnutrition criteria as a Nutrition Assessment Tool for Patients with Cancer

Nutrition ◽  
2021 ◽  
pp. 111379
Author(s):  
Kang-Ping Zhang ◽  
Meng Tang ◽  
Zhen-Ming Fu ◽  
Qi Zhang ◽  
Xi Zhang ◽  
...  
Keyword(s):  
Assessment Tool ◽  
Global Leadership ◽  
Nutrition Assessment ◽  
Patients With Cancer

Bereavement risk assessment of family caregivers of patients with cancer: Japanese version of the Bereavement Risk Assessment Tool

2018 ◽  
Vol 17 (04) ◽  
pp. 448-452
Author(s):  
Tomohiro Uchida ◽  
Noriaki Satake ◽  
Toshimichi Nakaho ◽  
Akira Inoue ◽  
Hidemitsu Saito
Keyword(s):  
Risk Assessment ◽  
Psychological Distress ◽  
Family Caregivers ◽  
Assessment Tool ◽  
Japanese Version ◽  
University Hospital ◽  
Risk Assessment Tool ◽  
Risk Level ◽  
Patients With Cancer ◽  
Distress Scale

AbstractObjectivesThe Bereavement Risk Assessment Tool (BRAT) seems to be useful in identifying those who are likely to suffer from the more severe consequences of bereavement. To date, however, only a few studies have examined bereavement risk using the BRAT. This study investigated bereavement risk in family caregivers of patients with cancer using the Japanese version of the Bereavement Risk Assessment Tool (BRAT-J). We also investigated the relationship of bereavement risk with psychological distress and resilience among caregivers to determine the validity of the BRAT-J.MethodsWe conducted family psychoeducation in the palliative care unit of Tohoku University Hospital with participants who were recruited in this study. Among the participants, 50 family caregivers provided their written informed consent and were included in this study. Participants were assessed using the BRAT-J and completed the Japanese version of the Kessler Psychological Distress Scale (K6) and the Tachikawa Resilience Scale (TRS).ResultsAccording to the BRAT-J, five individuals (10%) were in the high category of bereavement risk (level 4 or 5). We also found that family caregivers of patients experienced many different pressures, such as facing the unknown; their own work; and insufficient financial, practical, or physical resources. These issues are associated with various mental problems. Additionally, the level of bereavement risk was significantly correlated with K6 scores (ρ = 0.30, p = 0.032), and the TRS score (ρ = –0.44, p = 0.001). These correlations confirmed previous findings and that the BRAT-J can be an efficient screening tool for the bereavement risk of family caregivers of patients with cancer.Significance of resultsIt appears that the BRAT-J is useful in predicting the likelihood of difficulties or complications in bereavement for family caregivers and could help to provide support with these issues when needed.

Developing, implementing, and validating a social toxicity assessment tool of cancer (STAT-C).

2021 ◽  
Vol 39 (15_suppl) ◽  
pp. e24115-e24115
Author(s):  
Abdul-Rahman Jazieh ◽  
Hoda Jradi ◽  
Omar B. Da'ar ◽  
Mohammad Alkaiyat ◽  
Yousuf Zafar ◽  
...  
Keyword(s):  
Social Relations ◽  
Social Impact ◽  
Assessment Tool ◽  
Holistic Approach ◽  
Arabic Language ◽  
Toxicity Assessment ◽  
Face Validity ◽  
Patient Centered ◽  
Patients With Cancer ◽  
The Social

e24115 Background: The social impact of cancer on patients and their family is well known. Yet, unlike with physical and financial toxicities, no validated tools are available to measure this impact. This study aimed at developing, validating, and implementing a novel social toxicity assessment tool for patients with cancer diagnosis (STAT-C). Methods: Questions were generated through multiple steps including focus groups of patients, their families, and oncology care professionals. Content validity, internal consistency, face validity and factor analysis were conducted. The questionnaire (in Arabic language) was administered to 150 patients with cancer served at King Abdulaziz Medical City, Riyadh, Saudi, Arabia. Results: STAT-C contains 14 items covering three domains: Social Relations domain (eight questions) related to relationship with parents, spouse, children, siblings, friends, members of congregation, and caregiver; Social Activities domain (two questions) measures participation in social events and leisure; and Economic Impact domain (four questions) related to standard of living, finances, and loss of job. The total possible score for each patient for the 14 items in the tool varied between -28 and +28 (Range = 56). Dividing the range by three levels of a socioeconomic toxicity yielded the length of each level, which effectively defined the categories as- Severe social toxicity (SST score: -28 to -9.3), mild social toxicity (MST: -9.2 to 9.5) and no social toxicity (NST: 9.6 to 28). Conclusions: Our study revealed that STAT-C is a valid and reliable tool in assessing the social toxicity of cancer in Arabic-speaking patients. Validating the tool in an English-speaking population is planned. The tool should enable oncology professionals to deliver better patient-centered care as a component of a holistic approach.

scholarly journals Psychometric properties of an Australian supportive care needs assessment tool for Indigenous patients with cancer

Cancer ◽  
2015 ◽  
Vol 121 (17) ◽  
pp. 3018-3026 ◽  
Author(s):  
Gail Garvey ◽  
Vanessa L. Beesley ◽  
Monika Janda ◽  
Peter K. O'Rourke ◽  
Vincent Y.F. He ◽  
...  
Keyword(s):  
Supportive Care ◽  
Needs Assessment ◽  
Psychometric Properties ◽  
Assessment Tool ◽  
Supportive Care Needs ◽  
Care Needs ◽  
Patients With Cancer

scholarly journals Clinical Outcomes of Molecular Tumor Boards: A Systematic Review

2021 ◽  
pp. 1122-1132
Author(s):  
Kara L. Larson ◽  
Bin Huang ◽  
Heidi L. Weiss ◽  
Pam Hull ◽  
Philip M. Westgate ◽  
...  
Keyword(s):  
Systematic Review ◽  
Quality Assessment ◽  
Clinical Outcomes ◽  
Assessment Tool ◽  
Progression Free Survival ◽  
Control Group ◽  
Quality Assessment Tool ◽  
Free Survival ◽  
Patients With Cancer ◽  
Recommended Therapy

PURPOSE We conducted this systematic review to evaluate the clinical outcomes associated with molecular tumor board (MTB) review in patients with cancer. METHODS A systematic search of PubMed was performed to identify studies reporting clinical outcomes in patients with cancer who were reviewed by an MTB. To be included, studies had to report clinical outcomes, including clinical benefit, response, progression-free survival, or overall survival. Two reviewers independently selected studies and assessed quality with the Quality Assessment Tool for Before-After (Pre-Post) Studies with No Control Group or the Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies depending on the type of study being reviewed. RESULTS Fourteen studies were included with a total of 3,328 patients with cancer. All studies included patients without standard-of-care treatment options and usually with multiple prior lines of therapy. In studies reporting response rates, patients receiving MTB-recommended therapy had overall response rates ranging from 0% to 67%. In the only trial powered on clinical outcome and including a control group, the group receiving MTB-recommended therapy had significantly improved rate of progression-free survival compared with those receiving conventional therapy. CONCLUSION Although data quality is limited by a lack of prospective randomized controlled trials, MTBs appear to improve clinical outcomes for patients with cancer. Future research should concentrate on prospective trials and standardization of approach and outcomes.

scholarly journals Implementing a Method for Evaluating Patient-Reported Outcomes Associated With Oral Oncolytic Therapy

2017 ◽  
Vol 13 (4) ◽  
pp. e395-e400 ◽  
Author(s):  
Emily Mackler ◽  
Laura Petersen ◽  
Jane Severson ◽  
Douglas W. Blayney ◽  
Lydia L. Benitez ◽  
...  
Keyword(s):  
Quality Of Care ◽  
Patient Reported Outcomes ◽  
Assessment Tool ◽  
Symptom Burden ◽  
Oncolytic Therapy ◽  
Patients With Cancer ◽  
Patient Reported ◽  
Edmonton Symptom Assessment Scale ◽  
Oral Oncolytics

Introduction: The paradigm shift in health care toward value-based reimbursement has brought emphasis to providing better quality of care to patients with chronic diseases, including patients with cancer. In accordance with providing better quality of care to patients, there has been a growing interest in evaluating quality of life through patient-reported outcomes (PROs). The revised Edmonton Symptom Assessment Scale (ESAS-r) is a tool that can be used to assess PROs and has been validated for use in patients with cancer. This initiative sought to use this standard assessment tool to acquire PROs concerning symptom burden from patients prescribed oral oncolytics. Patients and Methods: Eight oncology practices in the state of Michigan used a modified ESAS-r to evaluate symptom burden of patients prescribed oral oncolytics before each outpatient visit. Thirteen symptoms were categorized as mild (0 to 3), moderate (4 to 6), or severe (7 to 10). Results: A total of 1,235 modified ESAS-r surveys were collected and analyzed; 82.5% of symptoms were categorized as mild, 11.9% of symptoms were categorized as moderate, and 5.6% of symptoms were categorized as severe. Conclusion: PROs can be evaluated through the use of a standardized tool, such as the ESAS-r, in oncology patients receiving oral oncolytic therapy. Implementing such a tool in both community and academic practices is feasible and may facilitate improvements in the quality of care.

Multiple Intelligences for Global Leadership Development

2017 ◽  
pp. 470-484 ◽  
Author(s):  
Julie Breithaupt ◽  
Regina Durante
Keyword(s):  
Leadership Development ◽  
Cultural Change ◽  
Cultural Sensitivity ◽  
Assessment Tool ◽  
Global Leadership ◽  
Leadership Programs ◽  
Multinational Organizations ◽  
Self Reflection ◽  
Global Leadership Development ◽  
Cultural Boundaries

Globalization has led to cultural change, convergence, and a rise in multinational organizations. Leaders who can work effectively across nations and cultures are in demand. Today's global leaders face increased complexity due to the need for cultural sensitivity and knowledge of other countries (House et al., 2004). Competent global leaders who can effectively navigate cross-cultural boundaries are more vital to the success of multinational organizations than in previous decades (Ang & Inkpen, 2008). Multinational organizations struggle in determining what knowledge, skills, and abilities are needed to develop competent global leaders (Caligiuri, 2006) for the 21st century. Many organizations understand that competent leadership will lead to a competitive business advantage and have begun focusing leadership programs on developing competencies for global leadership (Bird, 2008). This chapter considers the importance that personality traits, emotional, social, and cultural intelligence play in developing global leaders. It offers leaders an assessment tool for self-reflection and personal inquiry development.

Sign in / Sign up

Export Citation Format

Share Document